These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 7544637

  • 1. A monoclonal antibody with high affinity for a neo-antigenic site in fibrinogen degraded by polymorphonuclear leukocyte-derived elastase.
    Bos R, van Leuven CJ, Stolk J, Hiemstra PS, Dijkman JH, Nieuwenhuizen W.
    Blood Coagul Fibrinolysis; 1995 May; 6(3):259-67. PubMed ID: 7544637
    [Abstract] [Full Text] [Related]

  • 2. An enzyme immunoassay for polymorphonuclear leucocyte-mediated fibrinogenolysis.
    Bos R, van Leuven CJ, Stolk J, Hiemstra PS, Ronday HK, Nieuwenhuizen W.
    Eur J Clin Invest; 1997 Feb; 27(2):148-56. PubMed ID: 9061309
    [Abstract] [Full Text] [Related]

  • 3. A monoclonal antibody specific to the granulocyte-derived elastase-fragment D species of human fibrinogen and fibrin: its application to the measurement of granulocyte-derived elastase digests in plasma.
    Kohno I, Inuzuka K, Itoh Y, Nakahara K, Eguchi Y, Sugo T, Soe G, Sakata Y, Murayama H, Matsuda M.
    Blood; 2000 Mar 01; 95(5):1721-8. PubMed ID: 10688830
    [Abstract] [Full Text] [Related]

  • 4. Complement receptor type three (CD11b/CD18) of human polymorphonuclear leukocytes recognizes fibrinogen.
    Wright SD, Weitz JI, Huang AJ, Levin SM, Silverstein SC, Loike JD.
    Proc Natl Acad Sci U S A; 1988 Oct 01; 85(20):7734-8. PubMed ID: 2971974
    [Abstract] [Full Text] [Related]

  • 5. Chemical, biochemical, pharmacokinetic, and biological properties of L-680,833: a potent, orally active monocyclic beta-lactam inhibitor of human polymorphonuclear leukocyte elastase.
    Doherty JB, Shah SK, Finke PE, Dorn CP, Hagmann WK, Hale JJ, Kissinger AL, Thompson KR, Brause K, Chandler GO.
    Proc Natl Acad Sci U S A; 1993 Sep 15; 90(18):8727-31. PubMed ID: 8378355
    [Abstract] [Full Text] [Related]

  • 6. Potency of antileukoprotease and alpha 1-antitrypsin to inhibit degradation of fibrinogen by adherent polymorphonuclear leukocytes from normal subjects and patients with chronic granulomatous disease.
    Stolk J, Davies P, Kramps JA, Dijkman JH, Humes JJ, Knight WB, Green BG, Mumford R, Bonney RJ, Hanlon WA.
    Am J Respir Cell Mol Biol; 1992 May 15; 6(5):521-6. PubMed ID: 1316132
    [Abstract] [Full Text] [Related]

  • 7. Elastase-mediated fibrinogenolysis by chemoattractant-stimulated neutrophils occurs in the presence of physiologic concentrations of antiproteinases.
    Weitz JI, Huang AJ, Landman SL, Nicholson SC, Silverstein SC.
    J Exp Med; 1987 Dec 01; 166(6):1836-50. PubMed ID: 3681193
    [Abstract] [Full Text] [Related]

  • 8. Monoclonal antibodies to different neo-epitopes on fibrinogen and fibrin degradation products.
    Amiral J, Grosley M, Mimilla F, Plassart V, Chambrette B.
    Blood Coagul Fibrinolysis; 1990 Oct 01; 1(4-5):447-52. PubMed ID: 1723302
    [Abstract] [Full Text] [Related]

  • 9. Two antipeptide monoclonal antibodies that recognize adhesive sequences in fibrinogen: identification of antigenic determinants and unrelated sequences using synthetic combinatorial libraries.
    Pinilla C, Buencamino J, Appel JR, Houghten RA, Brassard JA, Ruggeri ZM.
    Biomed Pept Proteins Nucleic Acids; 1995 Oct 01; 1(3):199-204. PubMed ID: 9346853
    [Abstract] [Full Text] [Related]

  • 10. Formation of polymorphonuclear leukocyte elastase: alpha 1 proteinase inhibitor complex and A alpha (1-21) fibrinopeptide in human blood stimulated with the calcium ionophore A23187. A model to characterize inhibitors of polymorphonuclear leukocyte elastase.
    Pacholok SG, Davies P, Dorn C, Finke P, Hanlon WA, Mumford RA, Humes JL.
    Biochem Pharmacol; 1995 May 17; 49(10):1513-20. PubMed ID: 7763294
    [Abstract] [Full Text] [Related]

  • 11. Effects of human polymorphonuclear leukocyte elastase upon surfactant proteins in vitro.
    Liau DF, Yin NX, Huang J, Ryan SF.
    Biochim Biophys Acta; 1996 Jul 26; 1302(2):117-28. PubMed ID: 8695661
    [Abstract] [Full Text] [Related]

  • 12. Specificity of a monoclonal antibody for the NH2-terminal region of fibrin.
    Kudryk B, Rohoza A, Ahadi M, Chin J, Wiebe ME.
    Mol Immunol; 1984 Jan 26; 21(1):89-94. PubMed ID: 6200769
    [Abstract] [Full Text] [Related]

  • 13. The monoclonal antibody that recognizes an epitope in the C-terminal region of the fibrinogen alpha-chain reacts with soluble fibrin and fibrin monomer generated by thrombin but not with those formed as plasmin degradation products.
    Suzuki A, Ebinuma H, Matsuo M, Miyazaki O, Yago H.
    Thromb Res; 2007 Jan 26; 121(3):377-85. PubMed ID: 17561232
    [Abstract] [Full Text] [Related]

  • 14. Localization of sequence-determined neoepitopes and neutrophil digestion fragments of C-reactive protein utilizing monoclonal antibodies and synthetic peptides.
    Ying SC, Shephard E, de Beer FC, Siegel JN, Harris D, Gewurz BE, Fridkin M, Gewurz H.
    Mol Immunol; 1992 May 26; 29(5):677-87. PubMed ID: 1374844
    [Abstract] [Full Text] [Related]

  • 15. Human neutrophil elastase alters human alpha-thrombin function: limited proteolysis near the gamma-cleavage site results in decreased fibrinogen clotting and platelet-stimulatory activity.
    Brower MS, Walz DA, Garry KE, Fenton JW.
    Blood; 1987 Mar 26; 69(3):813-9. PubMed ID: 3101765
    [Abstract] [Full Text] [Related]

  • 16. Purification and partial characterization of a D-like fragment from human fibrinogen, produced by human leukocyte elastase.
    Sterrenberg L, Nieuwenhuizen W, Hermans J.
    Biochim Biophys Acta; 1983 Jan 25; 755(2):300-6. PubMed ID: 6550499
    [Abstract] [Full Text] [Related]

  • 17. Degradation of fibrinogen and cross-linked fibrin by human neutrophil elastase generates D-like fragments detected by ELISA but not latex D-dimer test.
    Bach-Gansmo ET, Godal HC, Skjønsberg OH.
    Thromb Res; 1998 Nov 01; 92(3):125-34. PubMed ID: 9806364
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Immunochemical discrimination of leukocyte elastase from plasmic degradation products of fibrinogen.
    Plow EF, Gramse M, Havemann K.
    J Lab Clin Med; 1983 Dec 01; 102(6):858-69. PubMed ID: 6227673
    [Abstract] [Full Text] [Related]

  • 20. Anticoagulant properties of purified X-like fragments of human fibrinogen produced by degradation with leukocyte elastase.
    Sterrenberg L, van Liempt GJ, Nieuwenhuizen W, Hermans J.
    Thromb Haemost; 1984 Jul 29; 51(3):398-402. PubMed ID: 6238443
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.